These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 2596475)
1. Recombinant human erythropoietin treatment may improve quality of life and cognitive function in chronic hemodialysis patients. Wolcott DL; Marsh JT; La Rue A; Carr C; Nissenson AR Am J Kidney Dis; 1989 Dec; 14(6):478-85. PubMed ID: 2596475 [TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin: impact on brain and cognitive function, exercise tolerance, sexual potency, and quality of life. Nissenson AR Semin Nephrol; 1989 Mar; 9(1 Suppl 2):25-31. PubMed ID: 2669083 [TBL] [Abstract][Full Text] [Related]
3. Improvements in quality of life following treatment with r-HuEPO in anemic hemodialysis patients. Delano BG Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):14-8. PubMed ID: 2757025 [TBL] [Abstract][Full Text] [Related]
4. Monitoring considerations in recombinant human erythropoietin therapy. Ogden DA Semin Nephrol; 1989 Mar; 9(1 Suppl 2):12-5. PubMed ID: 2669080 [TBL] [Abstract][Full Text] [Related]
5. [An echocardiographic study of the left ventricular functional indices in pediatric patients on hemodialysis and in treatment with recombinant human erythropoietin (r-HuEPO)]. Seracini D; Pollini I; Lavoratti GC; Pela I; Materassi M; Danti D; De Simone L; Favilli S; Manetti A Pediatr Med Chir; 1994; 16(4):389-92. PubMed ID: 7816703 [TBL] [Abstract][Full Text] [Related]
6. Effect of recombinant human erythropoietin on renal function in humans. Lim VS; Fangman J; Flanigan MJ; DeGowin RL; Abels RT Kidney Int; 1990 Jan; 37(1):131-6. PubMed ID: 2299799 [TBL] [Abstract][Full Text] [Related]
7. Who should receive recombinant human erythropoietin? Van Stone JC Semin Nephrol; 1989 Mar; 9(1 Suppl 2):3-7. PubMed ID: 2669084 [TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients. Revicki DA; Brown RE; Feeny DH; Henry D; Teehan BP; Rudnick MR; Benz RL Am J Kidney Dis; 1995 Apr; 25(4):548-54. PubMed ID: 7702049 [TBL] [Abstract][Full Text] [Related]
9. Normalization of serum prolactin levels in hemodialysis patients on recombinant human erythropoietin. Schaefer RM; Kokot F; Kuerner B; Zech M; Heidland A Int J Artif Organs; 1989 Jul; 12(7):445-9. PubMed ID: 2767790 [TBL] [Abstract][Full Text] [Related]
10. [The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration]. Zehnder C; Blumberg A Schweiz Med Wochenschr; 1990 Feb; 120(7):217-20. PubMed ID: 2309110 [TBL] [Abstract][Full Text] [Related]
11. The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function: a double-blind, placebo-controlled trial. Kleinman KS; Schweitzer SU; Perdue ST; Bleifer KH; Abels RI Am J Kidney Dis; 1989 Dec; 14(6):486-95. PubMed ID: 2688405 [TBL] [Abstract][Full Text] [Related]
12. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure. Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159 [TBL] [Abstract][Full Text] [Related]
13. Clinical effect of recombinant human erythropoietin on anemia associated with chronic renal failure. A multi-institutional study in Japan. Akizawa T; Koshikawa S; Takaku F; Urabe A; Akiyama N; Mimura N; Otsubo O; Nihei H; Suzuki Y; Kawaguchi Y Int J Artif Organs; 1988 Sep; 11(5):343-50. PubMed ID: 3056862 [TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of recombinant human erythropoietin in hemodialysis patients. Mohini R Semin Nephrol; 1989 Mar; 9(1 Suppl 1):16-21. PubMed ID: 2648516 [TBL] [Abstract][Full Text] [Related]
15. Improved sexual function in hemodialysis patients on recombinant erythropoietin: a possible role for prolactin. Schaefer RM; Kokot F; Wernze H; Geiger H; Heidland A Clin Nephrol; 1989 Jan; 31(1):1-5. PubMed ID: 2914405 [TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials. Henry DH; Beall GN; Benson CA; Carey J; Cone LA; Eron LJ; Fiala M; Fischl MA; Gabin SJ; Gottlieb MS Ann Intern Med; 1992 Nov; 117(9):739-48. PubMed ID: 1416576 [TBL] [Abstract][Full Text] [Related]
17. Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients. Abraham PA; Opsahl JA; Rachael KM; Asinger R; Halstenson CE Am J Nephrol; 1990; 10(2):128-36. PubMed ID: 2349956 [TBL] [Abstract][Full Text] [Related]
18. Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients. Roth D; Smith RD; Schulman G; Steinman TI; Hatch FE; Rudnick MR; Sloand JA; Freedman BI; Williams WW; Shadur CA Am J Kidney Dis; 1994 Nov; 24(5):777-84. PubMed ID: 7977319 [TBL] [Abstract][Full Text] [Related]
19. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis]. Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875 [TBL] [Abstract][Full Text] [Related]
20. Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end-stage renal disease-related anemia with erythropoietin. Moreno F; Aracil FJ; Pérez R; Valderrábano F Am J Kidney Dis; 1996 Apr; 27(4):548-56. PubMed ID: 8678066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]